Empery Asset Management, LP reports

Company location: New York, NY
Fiscal year end: 31 December

Empery Asset Management, LP has filed 476 SEC EDGAR filings since 31 Jul 2009

SEC filing history

Showing 76-100 of 473 matching filings.

Per page

25

Current page

4

SC 13G

SC 13G filing

Filing date: 11 Jan 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

VOLCON, INC.

Filing date: 11 Jan 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

CYNGN INC.

Filing date: 10 Jan 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

ELEVATION ONCOLOGY, INC.

Filing date: 09 Jan 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

SHARPS TECHNOLOGY INC.

Filing date: 09 Jan 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

SOBR SAFE, INC.

Filing date: 09 Jan 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

NUVVE HOLDING CORP.

Filing date: 09 Jan 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

X4 PHARMACEUTICALS, INC.

Filing date: 08 Jan 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

KIROMIC BIOPHARMA, INC.

Filing date: 08 Jan 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

REDHILL BIOPHARMA LTD.

Filing date: 08 Jan 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

PERMEX PETROLEUM CORP

Filing date: 08 Jan 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

REDHILL BIOPHARMA LTD.

Filing date: 13 Jan 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

X4 PHARMACEUTICALS, INC.

Filing date: 13 Jan 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

VOLCON, INC.

Filing date: 13 Jan 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

PERMEX PETROLEUM CORP.

Filing date: 12 Jan 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

KIROMIC BIOPHARMA, INC.

Filing date: 12 Jan 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

DIRECT DIGITAL HOLDINGS, INC.

Filing date: 12 Jan 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

ISPECIMEN INC.

Filing date: 12 Jan 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

13F-HR File 028-21771

13F-HR filing

Filing date: 14 Nov 2022
Reporting date: 30 Sep 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

13F-HR File 028-21771

13F-HR filing

Filing date: 12 Aug 2022
Reporting date: 30 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

13F-HR File 028-21771

13F-HR filing

Filing date: 16 May 2022
Reporting date: 31 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G

DIRECT DIGITAL HOLDINGS, INC.

Filing date: 18 Mar 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

13F-HR File 028-21771

13F-HR filing

Filing date: 11 Feb 2022
Reporting date: 31 Dec 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

TITAN PHARMACEUTICALS, INC.

Filing date: 24 Jan 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

KIORA PHARMACEUTICALS, INC.

Filing date: 24 Jan 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .